BioSpace News Archive

Business

Berkeley Lights Forms Strategic Scientific Advisory Board Featuring Distinguished Experts

The SSAB serves as a strategic resource for Berkeley Lights as it continues to build out its product portfolio in the areas of drug discovery and development, and cell therapy manufacturing.

December 4, 2017

·

2 min read

Business

Metrics Contract Services Appoints Associate Director of Pharmaceutical Development

Sadhale will manage all aspects of formulation development and manufacturing of a client’s clinical trial materials.

December 4, 2017

·

2 min read

Business

22nd Century Hires Former BAT Head of Plant Biotechnology

At 22nd Century, Dr. Tamburrino will assume the role of Vice President of Research and Development upon the retirement, at the end of this month, of Dr. Michael Moynihan.

December 4, 2017

·

5 min read

Pharm Country

AmerisourceBergen Closes $1.25 Billion Senior Note Offering

The offering was made pursuant to an effective shelf registration statement AmerisourceBergen filed with the Securities and Exchange Commission (the “SEC”) on November 24, 2015.

December 4, 2017

·

8 min read

Valeant Pharmaceuticals Announces Pricing of Private Offering of Senior Notes

The Notes will be guaranteed by each of the Company’s subsidiaries that are guarantors under the Company’s credit agreement and the Company’s existing senior notes.

December 4, 2017

·

4 min read

Business

Alligator Bioscience Expands Management Team

Dr Russell will be responsible for leading Alligator’s clinical team in progressing the company’s immuno-oncology projects towards proof of concept in cancer patients.

December 4, 2017

·

2 min read

Drug Development

Bayer Release: Updated Larotrectinib Pediatric Phase I Clinical Trial Data Demonstrates Response in TRK Fusion Cancers

These data are being presented today at the AACR Special Conference on Pediatric Cancer Research in Atlanta.

December 4, 2017

·

4 min read

Business

Acentrus Specialty Signs New Agreement With Pfizer Oncology

Pfizer is the first supplier that has been extended an agreement for its limited distribution drug portfolio of oral oncolytics by Acentrus.

December 4, 2017

·

2 min read

Valeant Pharma and One of its Subsidiaries Commence Cash Tender Offers for Up to $1,000,000,000 Outstanding Principal Amount

Valeant is the Offeror for the notes issued by it, and VPI is the Offeror for the notes issued by it.

December 4, 2017

·

12 min read

Drug Development

Ovid Therapeutics Presents New Data Demonstrating Potential of TAK-935/OV935 as a Novel Treatment for Developmental and Epileptic Encephalopathies at the American Epilepsy Society (AES) Annual Meeting

The data were presented at the American Epilepsy Society 71st Annual Meeting, taking place December 1-5, 2017, at the Walter E. Washington Convention Center in Washington, D.C.

December 4, 2017

·

10 min read